DrugDashboards

Market view

rasagiline mesylate · Powder

13 marketed package NDCs · 8 active manufacturers

Most dispensed: .5 mg · Tablet · #30 tablets/bottle · 1 mg · Tablet · #30 tablets/bottle

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble.

What changed in the last 90 days

Every detected change for rasagiline mesylate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • RasagilineAug 19, 2026
    Price up
    NADAC $0.95391 → $1.03186 per unit (+8.17%)
  • RasagilineAug 19, 2026
    Price down
    NADAC $0.57949 → $0.45452 per unit (-21.57%)
  • Price up
    NADAC $0.95391 → $1.03186 per unit (+8.17%)
  • Price down
    NADAC $0.57949 → $0.45452 per unit (-21.57%)
  • Mfr exited
    Avet Pharmaceuticals Inc. · rasagiline mesylate
  • Mfr exited
    Avet Pharmaceuticals Inc. · rasagiline mesylate
  • RasagilineJul 22, 2026
    Price down
    NADAC $0.6667 → $0.57949 per unit (-13.08%)
  • RasagilineJul 22, 2026
    Price down
    NADAC $0.9814 → $0.95391 per unit (-2.8%)
  • Price down
    NADAC $0.9814 → $0.95391 per unit (-2.8%)
  • Price down
    NADAC $0.6667 → $0.57949 per unit (-13.08%)

Same drug class

Other molecules FDA puts in Monoamine Oxidase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Rasagiline mesylate in shortage right now?
No. FDA does not currently list Rasagiline mesylate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Rasagiline mesylate?
14 companies have marketed Rasagiline mesylate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Rasagiline mesylate cost?
The typical pharmacy pays about $0.7432 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.